metronidazole braun 5 mg/ ml
b. braun melsungen ag - metronidazol - infusjonsvæske, oppløsning - 5 mg/ ml
metronidazol baxter viaflo 5 mg/ ml
baxter medical ab - metronidazol - infusjonsvæske, oppløsning - 5 mg/ ml
metronidazol actavis 500 mg
actavis group ptc ehf (1) - metronidazol - tablett, filmdrasjert - 500 mg
flagyl 400 mg
sanofi-aventis norge (3) - metronidazol - tablett, filmdrasjert - 400 mg
flagyl 500 mg
sanofi-aventis norge (3) - metronidazol - vagitorie - 500 mg
rozex 0.75 %
galderma nordic ab - metronidazol - krem - 0.75 %
rozex 0.75 %
galderma nordic ab - metronidazol - gel - 0.75 %
zidoval 7.5 mg/ g
viatris as - metronidazol - vaginalgel - 7.5 mg/ g
zavicefta
pfizer ireland pharmaceuticals - avibactam sodium, ceftazidime pentahydrate - pneumonia, bacterial; soft tissue infections; pneumonia; urinary tract infections; gram-negative bacterial infections - antibakterielle midler for systemisk bruk, - zavicefta is indicated in adults and paediatric patients aged 3 months and older for the treatment of the following infections:complicated intra-abdominal infection (ciai)complicated urinary tract infection (cuti), including pyelonephritishospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap)treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above. zavicefta is also indicated for the treatment of infections due to aerobic gram-negative organisms in adults and paediatric patients aged 3 months and older with limited treatment options. det bør vurderes å offisielle retningslinjer for riktig bruk av antibakterielle midler.